|
Corporate Social Responsibility
News
11.30.2007 - 12:47pm ET
|
CSR News from:
|
|
|
News Category:
|
|
Support AIDS Vaccine Research on World AIDS Day
Leading AIDS vaccine organization teams up with Yahoo! to raise US$100K
(CSRwire) NEW YORK - November 30, 2007 – In honor of World AIDS Day on December 1,
the International AIDS Vaccine Initiative (IAVI) and Yahoo! have joined
forces to raise US$100,000 to support pioneering technologies for AIDS
vaccine research.
IAVI and Yahoo! encourage individuals around the world to make a
contribution aimed at ending the AIDS pandemic. As a leading research and
advocacy organization dedicated to accelerating AIDS vaccine development,
IAVI recently launched an Innovation Fund to identify and test pioneering
ideas from outside the field that could lead to a much-needed
breakthrough. IAVI and a team of experts will comb the globe for novel,
unproven technologies that could revolutionize the way we view AIDS
vaccine research.
Thanks to the generosity of an anonymous donor, every dollar donated to
IAVI's Innovation Fund will be matched dollar for dollar up to US$100,000.
IAVI has been a top-rated charity for the past six years; approximately 90
percent of all IAVI funds go directly toward the organization’s core
initiatives aimed at accelerating AIDS vaccine development.
"As IAVI's first corporate donor, Yahoo! has been a supporter of AIDS
vaccines since 2001, and we are thrilled that Yahoo! is helping us to take
on this latest grant challenge," said Dr. Seth Berkley, President and CEO
of IAVI. "We hope that individuals worldwide will take this opportunity to
help further research to find a vaccine that will rid this world of the
devastation caused by AIDS."
Currently, most vaccine candidates in testing focus on activating one arm
of the immune system. Most experts believe that both arms will need to be
stimulated in order for a vaccine to be fully protective against HIV.
IAVI's Innovation Fund will target new technologies that can advance the
development of such a vaccine.
Every day another 7,000 people are infected with HIV. Despite advances
made, only 20 percent of HIV-infected individuals who urgently need
antiretroviral treatment in low- and middle-income countries have access
to it. AIDS is the fourth leading cause of death worldwide. An AIDS
vaccine offers the world’s best hope for ending this terrible
epidemic.
On December 1st, Yahoo! users can link directly from the Yahoo!
homepage, www.yahoo.com, to a microsite about IAVI
and AIDS vaccines or go to the microsite directly to make a donation by
clicking here.
About IAVI
The International AIDS Vaccine Initiative (IAVI) is a global
not-for-profit organization whose mission is to ensure the development of
safe, effective, accessible, preventive HIV vaccines for use throughout
the world. Founded in 1996 and operational in 24 countries, IAVI and its
network of collaborators research and develop vaccine candidates. IAVI's
financial and in-kind supporters include the Alfred P. Sloan Foundation,
the Bill & Melinda Gates Foundation, the Foundation for the National
Institutes of Health, The John D. Evans Foundation, The New York Community
Trust, the James B. Pendleton Charitable Trust, The Rockefeller Foundation,
The William and Flora Hewlett Foundation; the Governments of Canada,
Denmark, Ireland, The Netherlands, Norway, Spain, Sweden, the United
Kingdom, and the United States, the Basque Autonomous Government as well
as the European Union; multilateral organizations such as The World Bank;
corporate donors including BD (Becton, Dickinson & Co.), Continental
Airlines, Google Inc., Henry Schein, Inc., Merck & Co., Inc. and Pfizer
Inc; leading AIDS charities such as Broadway Cares/Equity Fights AIDS and
Until There's A Cure Foundation; other private donors such as The Haas
Trusts; and many generous individuals from around the world. For more
information, see www.iavi.org.
|
|